Revive Therapeutics Ltd (OTCMKTS:RVVTF) acquired IP to Psilocybin of PharmaTher Inc., which is a subsidiary of Newscope Capital Corporation (OTCMKTS:PHRRF), for CAD 10 million. Revive Therapeutics...
It seems like Revive Therapeutics Ltd (OTCMKTS:RVVTF) has promising progress in its operations. The company’s plans for initiating a Phase 3 study on Bucillamine are rolling...